regulatory

Digital

Digital mental health technologies and the changing face of ...

Digital Mental Health Technologies, from apps and online platforms to AI-powered tools, are fast being seen as essential to help close treatment gaps.

News

ImmunityBio rises as route opens to broader Anktiva label

Shares in ImmunityBio shot up after it agreed a path with the FDA that should allow it to refile for wider use of its bladder cancer drug Anktiva.

News

FDA seeks changes to GLP-1, flu shot labels

The FDA has asked manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but added warnings to flu shots.

R&D

Magnifying glass over years including 2026

Looking ahead to 2026 in biopharma

A look forward to trends to come in 2026, including AI-driven drug development, advanced modalities, and cardiometabolic disease therapies.

News

JPM: Is the UK's clinical trials sector turning a corner?

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

News

FDA removes barriers to cell, gene therapy development

FDA wants to exert regulatory flexibility on cell and gene therapies in an effort to bring them to patients more quickly and efficiently.

Digital mental health technologies and the changing face of ...

ImmunityBio rises as route opens to broader Anktiva label

FDA seeks changes to GLP-1, flu shot labels

Looking ahead to 2026 in biopharma

JPM: Is the UK's clinical trials sector turning a corner?

FDA removes barriers to cell, gene therapy development

LSX2026: On a therapeutic vision for ocular disease, with Al...

Using AI-driven synthetic personas to take your insights fur...

regulatory

Editor's Picks